Keros Therapeutics controller, VP finance Annita Tanini files initial beneficial ownership statement
KROS•Form 3 filing discloses shares and options
Keros Therapeutics corporate controller and VP of finance Annita Tanini filed a Form 3 disclosing 46,368 common shares.
The filing also reports employee stock options covering 71,100 shares, with exercise prices from $15.52 to $70.93.
